Therma Bright Inc.
Therma Bright Inc. TBRIF Peers
See (TBRIF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TBRIF | $0.01 | +9.00% | 4.95M | -1.09 | -$0.01 | N/A |
| SMMNY | $26.81 | -2.12% | 120.29B | 25.78 | $1.04 | +0.99% |
| SEMHF | $53.62 | -0.66% | 60.13B | 26.81 | $2.00 | +2.06% |
| RYLPF | $24.05 | -3.15% | 22.24B | 82.92 | $0.29 | +3.92% |
| SONVF | $323.21 | +2.29% | 19.26B | 28.13 | $11.49 | +1.76% |
| SONVY | $64.58 | +1.03% | 19.24B | 28.45 | $2.27 | +1.73% |
| SNNUF | $14.60 | +1.88% | 12.77B | 31.05 | $0.47 | +2.57% |
| CHEOY | $87.40 | +0.62% | 11.43B | 47.76 | $1.83 | +1.64% |
| CHEOF | $168.00 | -1.15% | 10.96B | 46.41 | $3.62 | +1.65% |
| WILYY | $18.78 | N/A | 8.00B | 18.59 | $1.01 | N/A |
Stock Comparison
TBRIF vs SMMNY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SMMNY has a market cap of 120.29B. Regarding current trading prices, TBRIF is priced at $0.01, while SMMNY trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SMMNY's P/E ratio is 25.78. In terms of profitability, TBRIF's ROE is -2.22%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, TBRIF and SMMNY have similar daily volatility (1.85).
TBRIF vs SEMHF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SEMHF has a market cap of 60.13B. Regarding current trading prices, TBRIF is priced at $0.01, while SEMHF trades at $53.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SEMHF's P/E ratio is 26.81. In terms of profitability, TBRIF's ROE is -2.22%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, TBRIF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs RYLPF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, RYLPF has a market cap of 22.24B. Regarding current trading prices, TBRIF is priced at $0.01, while RYLPF trades at $24.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas RYLPF's P/E ratio is 82.92. In terms of profitability, TBRIF's ROE is -2.22%, compared to RYLPF's ROE of -0.06%. Regarding short-term risk, TBRIF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs SONVF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SONVF has a market cap of 19.26B. Regarding current trading prices, TBRIF is priced at $0.01, while SONVF trades at $323.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SONVF's P/E ratio is 28.13. In terms of profitability, TBRIF's ROE is -2.22%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, TBRIF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs SONVY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SONVY has a market cap of 19.24B. Regarding current trading prices, TBRIF is priced at $0.01, while SONVY trades at $64.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SONVY's P/E ratio is 28.45. In terms of profitability, TBRIF's ROE is -2.22%, compared to SONVY's ROE of +0.26%. Regarding short-term risk, TBRIF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs SNNUF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SNNUF has a market cap of 12.77B. Regarding current trading prices, TBRIF is priced at $0.01, while SNNUF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SNNUF's P/E ratio is 31.05. In terms of profitability, TBRIF's ROE is -2.22%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, TBRIF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CHEOY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CHEOY has a market cap of 11.43B. Regarding current trading prices, TBRIF is priced at $0.01, while CHEOY trades at $87.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CHEOY's P/E ratio is 47.76. In terms of profitability, TBRIF's ROE is -2.22%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, TBRIF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CHEOF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CHEOF has a market cap of 10.96B. Regarding current trading prices, TBRIF is priced at $0.01, while CHEOF trades at $168.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CHEOF's P/E ratio is 46.41. In terms of profitability, TBRIF's ROE is -2.22%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, TBRIF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs WILYY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, WILYY has a market cap of 8.00B. Regarding current trading prices, TBRIF is priced at $0.01, while WILYY trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas WILYY's P/E ratio is 18.59. In terms of profitability, TBRIF's ROE is -2.22%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, TBRIF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs WILLF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, WILLF has a market cap of 7.46B. Regarding current trading prices, TBRIF is priced at $0.01, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas WILLF's P/E ratio is 18.13. In terms of profitability, TBRIF's ROE is -2.22%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, TBRIF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs GNGBY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, GNGBY has a market cap of 5.42B. Regarding current trading prices, TBRIF is priced at $0.01, while GNGBY trades at $19.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas GNGBY's P/E ratio is 35.09. In terms of profitability, TBRIF's ROE is -2.22%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, TBRIF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs GNGBF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, TBRIF is priced at $0.01, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, TBRIF's ROE is -2.22%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, TBRIF is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs AMBBY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, AMBBY has a market cap of 4.01B. Regarding current trading prices, TBRIF is priced at $0.01, while AMBBY trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas AMBBY's P/E ratio is 72.33. In terms of profitability, TBRIF's ROE is -2.22%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, TBRIF is less volatile compared to AMBBY. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs NHNKY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, NHNKY has a market cap of 3.91B. Regarding current trading prices, TBRIF is priced at $0.01, while NHNKY trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas NHNKY's P/E ratio is 16.89. In terms of profitability, TBRIF's ROE is -2.22%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, TBRIF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs AMBFF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, AMBFF has a market cap of 3.52B. Regarding current trading prices, TBRIF is priced at $0.01, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, TBRIF's ROE is -2.22%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, TBRIF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs NHNKF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, TBRIF is priced at $0.01, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, TBRIF's ROE is -2.22%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, TBRIF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs VTRLY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, TBRIF is priced at $0.01, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, TBRIF's ROE is -2.22%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, TBRIF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs GNNDY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, GNNDY has a market cap of 2.07B. Regarding current trading prices, TBRIF is priced at $0.01, while GNNDY trades at $42.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas GNNDY's P/E ratio is 17.03. In terms of profitability, TBRIF's ROE is -2.22%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, TBRIF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs STSEY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, TBRIF is priced at $0.01, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas STSEY's P/E ratio is 39.41. In terms of profitability, TBRIF's ROE is -2.22%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, TBRIF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs SSII Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SSII has a market cap of 1.95B. Regarding current trading prices, TBRIF is priced at $0.01, while SSII trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SSII's P/E ratio is -91.36. In terms of profitability, TBRIF's ROE is -2.22%, compared to SSII's ROE of -1.33%. Regarding short-term risk, TBRIF is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs GGNDF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, TBRIF is priced at $0.01, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas GGNDF's P/E ratio is 15.48. In terms of profitability, TBRIF's ROE is -2.22%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, TBRIF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs OSSFF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, TBRIF is priced at $0.01, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, TBRIF's ROE is -2.22%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, TBRIF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs DWRKF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, TBRIF is priced at $0.01, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, TBRIF's ROE is -2.22%, compared to DWRKF's ROE of N/A. Regarding short-term risk, TBRIF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs MCRPF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, TBRIF is priced at $0.01, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, TBRIF's ROE is -2.22%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, TBRIF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs OSSUY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, TBRIF is priced at $0.01, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, TBRIF's ROE is -2.22%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, TBRIF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs MEDGF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, TBRIF is priced at $0.01, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, TBRIF's ROE is -2.22%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, TBRIF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs DRWKF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, DRWKF has a market cap of 1.17B. Regarding current trading prices, TBRIF is priced at $0.01, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas DRWKF's P/E ratio is 9.01. In terms of profitability, TBRIF's ROE is -2.22%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, TBRIF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs XVIPF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, TBRIF is priced at $0.01, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, TBRIF's ROE is -2.22%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, TBRIF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs LFTSF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, TBRIF is priced at $0.01, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, TBRIF's ROE is -2.22%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, TBRIF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs DGWPF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, DGWPF has a market cap of 925.04M. Regarding current trading prices, TBRIF is priced at $0.01, while DGWPF trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas DGWPF's P/E ratio is 6.88. In terms of profitability, TBRIF's ROE is -2.22%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, TBRIF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs ELEAF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, TBRIF is priced at $0.01, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas ELEAF's P/E ratio is 12.22. In terms of profitability, TBRIF's ROE is -2.22%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, TBRIF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CALZF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CALZF has a market cap of 829.01M. Regarding current trading prices, TBRIF is priced at $0.01, while CALZF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CALZF's P/E ratio is 120.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, TBRIF is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs MDRSF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, TBRIF is priced at $0.01, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, TBRIF's ROE is -2.22%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, TBRIF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs AVMR Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, TBRIF is priced at $0.01, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas AVMR's P/E ratio is -18.34. In terms of profitability, TBRIF's ROE is -2.22%, compared to AVMR's ROE of -0.24%. Regarding short-term risk, TBRIF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CLVSF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, TBRIF is priced at $0.01, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, TBRIF's ROE is -2.22%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, TBRIF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs HYBT Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, TBRIF is priced at $0.01, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas HYBT's P/E ratio is N/A. In terms of profitability, TBRIF's ROE is -2.22%, compared to HYBT's ROE of -0.02%. Regarding short-term risk, TBRIF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs IOBCF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, IOBCF has a market cap of 326.64M. Regarding current trading prices, TBRIF is priced at $0.01, while IOBCF trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas IOBCF's P/E ratio is 37.17. In terms of profitability, TBRIF's ROE is -2.22%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, TBRIF is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs SNWV Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SNWV has a market cap of 293.04M. Regarding current trading prices, TBRIF is priced at $0.01, while SNWV trades at $34.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SNWV's P/E ratio is -5.50. In terms of profitability, TBRIF's ROE is -2.22%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, TBRIF is less volatile compared to SNWV. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs EAPIF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, TBRIF is priced at $0.01, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, TBRIF's ROE is -2.22%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, TBRIF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CSSPF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, TBRIF is priced at $0.01, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, TBRIF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CYBQY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CYBQY has a market cap of 261.21M. Regarding current trading prices, TBRIF is priced at $0.01, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, TBRIF's ROE is -2.22%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, TBRIF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CLLKF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CLLKF has a market cap of 259.03M. Regarding current trading prices, TBRIF is priced at $0.01, while CLLKF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CLLKF's P/E ratio is -8.52. In terms of profitability, TBRIF's ROE is -2.22%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, TBRIF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs HTLZF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, TBRIF is priced at $0.01, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, TBRIF's ROE is -2.22%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, TBRIF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs BCCOY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, BCCOY has a market cap of 221.56M. Regarding current trading prices, TBRIF is priced at $0.01, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, TBRIF's ROE is -2.22%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, TBRIF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs IMPZY Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, TBRIF is priced at $0.01, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, TBRIF's ROE is -2.22%, compared to IMPZY's ROE of -3.64%. Regarding short-term risk, TBRIF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs AVHHL Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, AVHHL has a market cap of 191.65M. Regarding current trading prices, TBRIF is priced at $0.01, while AVHHL trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas AVHHL's P/E ratio is -3.25. In terms of profitability, TBRIF's ROE is -2.22%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, TBRIF is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CYBQF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, TBRIF is priced at $0.01, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, TBRIF's ROE is -2.22%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, TBRIF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs BRNHF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, TBRIF is priced at $0.01, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, TBRIF's ROE is -2.22%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, TBRIF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs EKDHF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, TBRIF is priced at $0.01, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, TBRIF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs JMDMF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, TBRIF is priced at $0.01, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, TBRIF's ROE is -2.22%, compared to JMDMF's ROE of N/A. Regarding short-term risk, TBRIF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs PXMBF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, PXMBF has a market cap of 149.60M. Regarding current trading prices, TBRIF is priced at $0.01, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, TBRIF's ROE is -2.22%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, TBRIF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs BRSYF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, TBRIF is priced at $0.01, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas BRSYF's P/E ratio is 37.78. In terms of profitability, TBRIF's ROE is -2.22%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, TBRIF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs AMEUF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, TBRIF is priced at $0.01, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, TBRIF's ROE is -2.22%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, TBRIF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs VMTHF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, TBRIF is priced at $0.01, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas VMTHF's P/E ratio is -1.14. In terms of profitability, TBRIF's ROE is -2.22%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, TBRIF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs FDMDF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, TBRIF is priced at $0.01, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, TBRIF's ROE is -2.22%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, TBRIF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs RSHUF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, TBRIF is priced at $0.01, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, TBRIF's ROE is -2.22%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, TBRIF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs CKMTF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, TBRIF is priced at $0.01, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, TBRIF's ROE is -2.22%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, TBRIF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs SOMNF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, TBRIF is priced at $0.01, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, TBRIF is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs DMTRF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, TBRIF is priced at $0.01, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, TBRIF's ROE is -2.22%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, TBRIF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs IPDQF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, TBRIF is priced at $0.01, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, TBRIF's ROE is -2.22%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, TBRIF is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs SNZZF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, TBRIF is priced at $0.01, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, TBRIF's ROE is -2.22%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, TBRIF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs RDGL Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, RDGL has a market cap of 59.91M. Regarding current trading prices, TBRIF is priced at $0.01, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas RDGL's P/E ratio is -13.21. In terms of profitability, TBRIF's ROE is -2.22%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, TBRIF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs BLOZF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, BLOZF has a market cap of 51.32M. Regarding current trading prices, TBRIF is priced at $0.01, while BLOZF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas BLOZF's P/E ratio is -22.28. In terms of profitability, TBRIF's ROE is -2.22%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, TBRIF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs NVYTF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, TBRIF is priced at $0.01, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, TBRIF's ROE is -2.22%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, TBRIF is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs TLTFF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, TLTFF has a market cap of 32.97M. Regarding current trading prices, TBRIF is priced at $0.01, while TLTFF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas TLTFF's P/E ratio is -13.30. In terms of profitability, TBRIF's ROE is -2.22%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, TBRIF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs PYNKF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, PYNKF has a market cap of 28.70M. Regarding current trading prices, TBRIF is priced at $0.01, while PYNKF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas PYNKF's P/E ratio is -1.71. In terms of profitability, TBRIF's ROE is -2.22%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, TBRIF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs ELXMF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, TBRIF is priced at $0.01, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, TBRIF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs KBBTF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, TBRIF is priced at $0.01, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, TBRIF's ROE is -2.22%, compared to KBBTF's ROE of N/A. Regarding short-term risk, TBRIF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs EMITF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, TBRIF is priced at $0.01, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas EMITF's P/E ratio is -14.29. In terms of profitability, TBRIF's ROE is -2.22%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, TBRIF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs POSC Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, POSC has a market cap of 20.70M. Regarding current trading prices, TBRIF is priced at $0.01, while POSC trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas POSC's P/E ratio is 0.39. In terms of profitability, TBRIF's ROE is -2.22%, compared to POSC's ROE of +9.25%. Regarding short-term risk, TBRIF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs RMSL Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, RMSL has a market cap of 18.12M. Regarding current trading prices, TBRIF is priced at $0.01, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas RMSL's P/E ratio is 1.18. In terms of profitability, TBRIF's ROE is -2.22%, compared to RMSL's ROE of -1.94%. Regarding short-term risk, TBRIF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs ASAPF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, ASAPF has a market cap of 16.99M. Regarding current trading prices, TBRIF is priced at $0.01, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas ASAPF's P/E ratio is -22.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, TBRIF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs VPTDF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, VPTDF has a market cap of 14.71M. Regarding current trading prices, TBRIF is priced at $0.01, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas VPTDF's P/E ratio is -4.51. In terms of profitability, TBRIF's ROE is -2.22%, compared to VPTDF's ROE of +3.89%. Regarding short-term risk, TBRIF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs TMDIF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, TBRIF is priced at $0.01, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, TBRIF's ROE is -2.22%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, TBRIF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs DIZTF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, TBRIF is priced at $0.01, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, TBRIF's ROE is -2.22%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, TBRIF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs PLLWF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, TBRIF is priced at $0.01, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, TBRIF's ROE is -2.22%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, TBRIF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs MDXHF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, MDXHF has a market cap of 12.26M. Regarding current trading prices, TBRIF is priced at $0.01, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, TBRIF's ROE is -2.22%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, TBRIF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs IMEXF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, IMEXF has a market cap of 11.61M. Regarding current trading prices, TBRIF is priced at $0.01, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas IMEXF's P/E ratio is N/A. In terms of profitability, TBRIF's ROE is -2.22%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, TBRIF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs NGMDF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, NGMDF has a market cap of 11.51M. Regarding current trading prices, TBRIF is priced at $0.01, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas NGMDF's P/E ratio is -5.50. In terms of profitability, TBRIF's ROE is -2.22%, compared to NGMDF's ROE of +2.16%. Regarding short-term risk, TBRIF is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs ATBPF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, TBRIF is priced at $0.01, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, TBRIF's ROE is -2.22%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, TBRIF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs LXXGF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, TBRIF is priced at $0.01, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, TBRIF's ROE is -2.22%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, TBRIF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs IRME Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, IRME has a market cap of 8.28M. Regarding current trading prices, TBRIF is priced at $0.01, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas IRME's P/E ratio is -3.83. In terms of profitability, TBRIF's ROE is -2.22%, compared to IRME's ROE of +506.40%. Regarding short-term risk, TBRIF is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs GTHP Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, GTHP has a market cap of 7.80M. Regarding current trading prices, TBRIF is priced at $0.01, while GTHP trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas GTHP's P/E ratio is -2.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to GTHP's ROE of +0.56%. Regarding short-term risk, TBRIF is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs MKEAF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, MKEAF has a market cap of 6.59M. Regarding current trading prices, TBRIF is priced at $0.01, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, TBRIF's ROE is -2.22%, compared to MKEAF's ROE of +0.60%. Regarding short-term risk, TBRIF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs DTXMF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, TBRIF is priced at $0.01, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, TBRIF's ROE is -2.22%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, TBRIF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs QLIS Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, TBRIF is priced at $0.01, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas QLIS's P/E ratio is 2.22. In terms of profitability, TBRIF's ROE is -2.22%, compared to QLIS's ROE of -8.21%. Regarding short-term risk, TBRIF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs RHNMF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, TBRIF is priced at $0.01, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, TBRIF's ROE is -2.22%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, TBRIF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs VYCO Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, VYCO has a market cap of 4.94M. Regarding current trading prices, TBRIF is priced at $0.01, while VYCO trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas VYCO's P/E ratio is -14.80. In terms of profitability, TBRIF's ROE is -2.22%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, TBRIF is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs MICR Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, TBRIF is priced at $0.01, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas MICR's P/E ratio is -3.47. In terms of profitability, TBRIF's ROE is -2.22%, compared to MICR's ROE of -0.25%. Regarding short-term risk, TBRIF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs FZMD Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, TBRIF is priced at $0.01, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas FZMD's P/E ratio is 1.20. In terms of profitability, TBRIF's ROE is -2.22%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, TBRIF is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs ADMT Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, ADMT has a market cap of 4.30M. Regarding current trading prices, TBRIF is priced at $0.01, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas ADMT's P/E ratio is -6.36. In terms of profitability, TBRIF's ROE is -2.22%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, TBRIF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs NUMD Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, TBRIF is priced at $0.01, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas NUMD's P/E ratio is 5.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, TBRIF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs LBLTF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, TBRIF is priced at $0.01, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, TBRIF's ROE is -2.22%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, TBRIF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs BIEL Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, TBRIF is priced at $0.01, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas BIEL's P/E ratio is N/A. In terms of profitability, TBRIF's ROE is -2.22%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, TBRIF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs VANIW Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, TBRIF is priced at $0.01, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas VANIW's P/E ratio is N/A. In terms of profitability, TBRIF's ROE is -2.22%, compared to VANIW's ROE of -1.06%. Regarding short-term risk, TBRIF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs ALRTF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, ALRTF has a market cap of 2.92M. Regarding current trading prices, TBRIF is priced at $0.01, while ALRTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas ALRTF's P/E ratio is -0.15. In terms of profitability, TBRIF's ROE is -2.22%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, TBRIF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs KLYG Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, KLYG has a market cap of 2.27M. Regarding current trading prices, TBRIF is priced at $0.01, while KLYG trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas KLYG's P/E ratio is -18.00. In terms of profitability, TBRIF's ROE is -2.22%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, TBRIF is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs PMEDF Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, TBRIF is priced at $0.01, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, TBRIF's ROE is -2.22%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, TBRIF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for TBRIF.
TBRIF vs LLBO Comparison
TBRIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TBRIF stands at 4.95M. In comparison, LLBO has a market cap of 2.17M. Regarding current trading prices, TBRIF is priced at $0.01, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TBRIF currently has a P/E ratio of -1.09, whereas LLBO's P/E ratio is N/A. In terms of profitability, TBRIF's ROE is -2.22%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, TBRIF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for TBRIF.